Nelson Quoted on Bayh-Dole Act as a Potential Tool to Regulate Drug Pricing
Partner Kevin Nelson was quoted on the Knowledge Ecology International’s urging of the National Institutes of Health (NIH) to leverage the Bayh-Dole Act in order to combat rising drug prices.
In the event of a drug not meeting public health requirements, the Bayh-Dole Act gives the NIH the ability to take over a drug’s patent title, force the company to license the patent out to another company, or make the companies adjust the drug’s price.
Kevin said the Bayh-Dole tactic would be “valuable in small doses,” with the government possibly being able to get the prices down on certain drugs or at least for a certain group of people, such as KEI’s petitioning certain drugmakers to provide certain drugs to the U.S. Department of Veteran Affairs at cost.
Read the full article here. (Subscription required)
Smart In Your World
Your goals define our mission. Whether an immediate need or a long-term objective, ArentFox Schiff helps you reach your full potential. As industry insiders, we partner with you to develop practical business strategies and sophisticated legal solutions to achieve today’s targets and anticipate tomorrow’s problems. We get you across the finish line.
Contacts
-
Contact:
Nathan Carlile, Head of Firmwide Communications
- Related Industries
- Related Practices